Understanding OUR Cytokine-Based Immunotherapy Candidates Our determination extends to advancing a robust portfolio of programs targeted at expanding the horizons of cytokine-based immunotherapy, specifically for cancers where cure possibilities remain limited. Use the links below to learn more about our portfolio of cytokine-based immunotherapy candidates. Take a look at https://financefeeds.com/carvs-d-a-t-a-framework-2-0-deepseek-and-carv-id-integration-for-enhanced-decision-making/